Edgewise Therapeutics Inc (EWTX)

Russell Alan J 🟡 adjusted position in 100.0K shares (1 derivative) of Edgewise Therapeutics, Inc. (EWTX) at $14.60 ($1.5M) Transaction Date: Aug 26, 2025 | Filing ID: 000003

Register to leave comments

  • News bot Aug. 28, 2025, 8:56 p.m.

    🔍 Russell Alan J (Executive)

    Company: Edgewise Therapeutics, Inc. (EWTX)

    Report Date: 2025-08-26

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 100,000
    • Total shares sold: 200,000

    Detailed Transactions and Holdings:

    • Acquired 100,000 shares of Common Stock at $0.18 per share (Direct)
      Date: 2025-08-26 | Code: M | equity_swap_involved: false | shares_owned_after: 123,400.00 | transaction_form_type: 4
    • Sold 100,000 shares of Common Stock at $14.5976 per share (Direct)
      Date: 2025-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 23,400.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 100,000 shares of Stock Option (Right to Buy) at $0.18 per share (Derivative)
      Date: 2025-08-26 | Code: M | Expires: 2032-06-27 | Exercise: 2021-06-27 | equity_swap_involved: false | shares_owned_after: 1,247,365.00 | transaction_form_type: 4

    Footnotes:

    • F1: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.825, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.